7 September 2024 in Nature Communications
DNA-protein interactions exert the fundamental structure of many pivotal biological processes, such as DNA replication, transcription, and gene regulation. However, accurate and efficient computational methods for identifying these interactions are still lacking. In this study, we propose a method ESM-DBP through refining the DNA-binding protein sequence repertory and domain-adaptive pretraining based the general protein language model. Our method considers the lacking exploration of general language model for DNA-binding protein domain-specific knowledge, so we screen out 170,264 DNA-binding protein sequences to construct the domain-adaptive language model. Experimental results on four downstream tasks show that ESM-DBP provides a better feature representation of DNA-binding protein compared to the original language model, resulting in improved prediction performance and outperforming the state-of-the-art methods. Moreover, ESM-DBP can still perform well even for those sequences with only a few homologous sequences. ChIP-seq on two predicted cases further support the validity of the proposed method.
3 September 2023 in Computers in Biology and Medicine
13 March 2025 in ACM Transactions on Management Information Systems
The rapidly evolving field of Large Language Models (LLMs) holds immense promise for healthcare, particularly in medication guidance and adverse drug reaction prediction. Despite their potential, existing LLMs face challenges in dealing with complex polypharmacy scenarios and often grapple with data lag issues. To address these limitations, we introduce an LLM-based Chinese medication guidance system, called ShennongMGS, specifically tailored for robust medication guidance and adverse drug reaction predictions. Our system transforms multi-source heterogeneous medication information into a knowledge graph and employs a two-stage training strategy to construct a specialized LLM (ShennongGPT). This method enables the simulation of professional pharmacists’ decision-making processes and incorporates the capability for knowledge self-updating, thereby significantly enhancing drug safety and the overall quality of medical services. Rigorously evaluated by medical professionals and artificial intelligence experts, our method demonstrates superiority, outperforming existing general and specialized LLMs in performance.
10 September 2023 in CCF Transactions on High Performance Computing